Supported by over 90 scientific publications from across the globe.
It is estimated that by 2050: 5 billion people, half of the global population, could have myopia¹.
Annual myopia progression rate is most rapid under 10 years of age². Significantly greater rates of progression can be seen especially in children with high myopia¹.
High myopia could affect 1 billion people, or 10% of the global population by 2050¹.
HOYA Vision Care is committed to continue fighting this problem through advances in technology and innovation, allowing children to lead fuller, and more inclusive lives. Together, we are shaping the future of vision care with MiYOSMART.
With the exclusive non-invasive D.I.M.S. Technology, MiYOSMART spectacle lens corrects the visual defect on its entire surface and has a ring shaped treatment area to slow down myopia progression. The alternation of the focus and defocus are provides clear vision and manages myopia simultaneously.³
MiYOSMART based on revolutionary Defocus Incorporated Multiple Segments (D.I.M.S.) Technology was developed in cooperation with The Hong Kong Polytechnic University in 2014. MiYOSMART is easy to fit, just like regular single vision lens. There are no limitations for the frame choice.
In 2018, the MiYOSMART lens won the Gold Prize, Grand Award & Special Gold Award International Exhibition of Inventions of Geneva, Switzerland. In 2020, it won the Silmo d’Or Award in the Vision category at the Silmo Paris Optical Fair.
We are excited to introduce a broader power range of MiYOSMART clear spectacle lenses, accommodating prescriptions up to −13.00D. With this extended power range, MiYOSMART spectacle lenses can better serve myopic patients with high prescriptions, meeting the diverse needs of the myopic population more effectively.
MiYOSMART now provides extensive features to improve vision outcomes in as many children as possible.
Extended Power Range
NOW up to -13.00 D (+4.00 CYL), accommodating high myopia and astigmatism, with the highest minus power of up to -13.00D with +4.00 CYL.
Larger Lens Diameter
This aims to meet every child’s needs and morphology, allowing them to find the perfect style to suit their active lifestyle.
Optimized Edge Thickness
This enhances the aesthetic appeal of the lens, addressing a common concern related to the appearance of thick high-prescription lenses.
Myopic children who wear spectacle lenses need a solution that will slow myopia progression, as well as protecting them from harmful UV rays and intense sunlight MiYOSMART sun.
More than 90 publications from across the globe conducted on the MiYOSMART D.I.M.S. Technology over the years.
Comparison of Myopia Progression in Individuals Wearing Defocus Incorporated Multiple Segments (DIMS) Spectacle Lenses for 8 Years versus Shorter Durations
Long-term myopia management effect and safety in children wearing DIMS spectacle lenses for 6 years.
Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomized clinical trial (BJO).
Here you can find a summary of all the studies involving MiYOSMART to date.
Following an in-depth review by the French Health Authority (HAS), France will become the first country in the European Union to offer reimbursement for HOYA Vision Care’s MiYOSMART myopia control spectacle lenses
HOYA Vision Care, a global leader in eye care technology, today presented its latest clinical evidence at the 16th Annual European Academy of Optometry and Optics (EAOO) Conference in Ljubljana, Slovenia.
At HOYA, we are ready to answer any questions you might have, explore our potential partnership and hear the ideas you want to share with us. Get in touch with us by completing the form below.
Sources: